
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops prod... Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1201 | 7.90131578947 | 1.52 | 2.09 | 1.35 | 608074 | 1.82419733 | CS |
4 | -0.3799 | -18.8069306931 | 2.02 | 2.09 | 1.35 | 215054 | 1.78141838 | CS |
12 | -2.2499 | -57.8380462725 | 3.89 | 5.95 | 1.35 | 138842 | 2.47604131 | CS |
26 | -1.5399 | -48.4245283019 | 3.18 | 5.95 | 1.35 | 81072 | 2.70268535 | CS |
52 | -2.3299 | -58.6876574307 | 3.97 | 5.99 | 1.35 | 51048 | 3.06796468 | CS |
156 | -2.3169 | -58.5519332828 | 3.957 | 9.6799 | 0.6706 | 346007 | 3.92505013 | CS |
260 | -23.7599 | -93.5429133858 | 25.4 | 37.7 | 0.6706 | 589405 | 15.4372196 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관